A single blood marker may quietly signal dementia risk decades in advance. Scientists at the…
Browsing: Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerative disorder that is the most common cause of dementia, affecting memory, thinking, and behavior. It typically begins with mild memory loss and gradually worsens, eventually interfering with daily tasks and cognitive function. Characterized by the buildup of abnormal protein deposits—amyloid plaques and tau tangles—in the brain, Alzheimer’s is currently incurable, though research is rapidly evolving. Ongoing scientific studies are exploring its causes, early detection methods, genetic risk factors, and potential treatments, with the goal of better understanding and ultimately halting or reversing the disease.
Scientists have developed a new class of microscopic antibody fragments capable of functioning inside human…
A newly identified enzyme target may open an alternative path for treating Alzheimer’s disease. Scientists…
A new single-cell atlas shows how epigenetic changes reshape brain cells during aging, revealing genomic…
New insights suggest that Alzheimer’s cannot be tackled through a single pathway, as its roots…
A growing body of evidence suggests that a single gene, APOE, may play a far…
A new study suggests that two of Alzheimer’s disease’s most debated players may be more…
A long-term Swedish study suggests that the relationship between diet and dementia may be more…
New findings suggest that targeting inflammation in Alzheimer’s may matter as much as targeting protein…
A long-running study suggests that the MIND diet may be linked to slower structural brain…
Research from UC Santa Cruz indicates that the P3 peptide—an alternative cleavage product of the…
A newly identified role for the neuronal MPS shows it controls nutrient uptake by acting…
Nearly half of dementia cases may be influenced by modifiable factors like smoking, cardiovascular disease,…
By watching Alzheimer’s-related protein clumping unfold second by second, researchers have uncovered new clues about…
Scientists have identified damaged brain “cleanup” cells called tanycytes as a possible reason toxic tau…
New noninvasive tools reveal that subtle shifts in brain blood flow and oxygen use may…
Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It…
Scientists show that lecanemab clears amyloid plaques by engaging microglia through its Fc fragment, defining…